首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2008082

重組人白蛋白市場：依原料、應用、最終使用者及地區分類

rHu Albumin Market, By Source, By Application, By End User, By Geography

出版日期: 2026年03月16日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年重組人白蛋白市場規模估計為876億美元，預計2033年將達2778億美元。預計2026年至2033年，其複合年成長率將達13.6%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	876億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	13.60%	預計金額（2033 年）	2778億美元

生物製藥是指利用生物技術，以生物來源的原料為原料生產的藥物。這些藥物通常以組織培養方法生產，利用幹細胞、哺乳動物細胞和其他類似材料。

組織培養方法依賴細胞培養基。這些培養基含有許多必需成分，包括碳水化合物、胺基酸、維生素、礦物質和pH緩衝系統，這些成分對於維持健康的細胞培養以及提供重組治療分子和生物製藥生產所需的營養素至關重要。

重組人體血清蛋白是細胞培養中的重要成分。重組人體血清蛋白（rHu）廣泛應用於細胞培養基和幹細胞治療。它主要作為細胞培養基的營養補充劑和穩定劑。此外，它在幹細胞治療的冷凍保存過程中也扮演著重要角色。

市場動態

市場參與企業正著力於多種策略，包括分銷協議，預計這些策略將在預測期內推動市場成長。 2021年4月，以科學為主導的生物技術公司Albumedix宣布，已與知名試劑供應商FUJIFILM膠片和光純藥株式會社達成分銷協議，其產品將在日本和中國（包括香港）銷售。

研究機構和學術機構正集中精力進行重組人白蛋白（rHu白蛋白）相關的研發活動，預計將推動全球rHu白蛋白市場在預測期內的成長。例如，2019年6月，位於長春的中國領先研究型大學附屬吉林大學第一醫院啟動了一項I期、單中心、隨機、雙盲、安慰劑對照、單劑量遞增試驗，旨在評估重組人體血清蛋白注射液在接受腹水治療的健康志願者中的安全性、耐受性、藥代動力學和免疫抗原性。

預計該地區重組人白蛋白（rHu白蛋白）研發活動的增加將推動全球rHu白蛋白市場的成長。例如，根據clinicaltrials.gov網站上發表的一項研究，北京一家以研發為導向的高科技公司Protgen Ltd於2021年4月8日啟動了一項試驗。本試驗採用單中心、隨機、雙盲、劑量遞增、安慰劑對照設計，旨在評估健康受試者單次注射重組人血清白蛋白的安全性、耐受性、藥物動力學和有效性。該試驗預計於2022年12月31日完成。

本報告的主要特點

本報告對全球重組人白蛋白市場進行了詳細分析，包括市場規模和預測期（2026-2033 年）的複合年成長率，以 2025 年為基準年。
此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文根據以下參數，介紹了全球 rHu 白蛋白市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球重組人白蛋白市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球重組人白蛋白市場中使用的各種策略矩陣來促進決策。

北美洲
美國
加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

公司簡介
- Merck KGaA
- HiMedia Laboratories Pvt. Ltd.
- Albumin Bioscience
- Albumedix
- ScienCell Research Laboratories, Inc.
- InVitria
- Lazuline Biotech Private Limited
- Lee Biosolutions, Inc.
- Abcam Plc
- Shandong Kingtone Biotechnology Co.,Ltd.

第9章

分析方法
關於 Coherent Market Insights
聯絡地址

簡介目錄

Product Code: CMI5040

rHu Albumin Market is estimated to be valued at USD 87.6 Bn in 2026 and is expected to reach USD 277.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 87.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	13.60%	2033 Value Projection:	USD 277.8 Bn

A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. They are manufactured using stem cells, mammalian cells, etc., through tissue culture methods.

Tissue culture methods rely on cell culture medium, which contains a number of essential components such as carbohydrates, amino acids, vitamins, minerals, and a pH buffer system that keep the cell culture healthy and supply nutrition for the production of therapeutic recombinant molecules or biopharmaceuticals.

One such component of cell culture is recombinant human albumin. Recombinant human albumin (rHu) has applications in cell culture media and stem cell therapy. It is particularly a nutrient supplement and stabilizer in the cell culture medium. Moreover, it plays a role in cryopreservation for stem cell therapies.

Market Dynamics

Market players are focusing on various strategies such as distribution agreements which is expected to drive market growth over the forecast period. In April 2021, Albumedix, a science-driven, biotechnology Company, announced that they had entered into a distribution agreement with established and well recognized reagent supplier Fujifilm Wako Pure Chemical Corporation in Japan and China including Hong Kong.

Research and/or academic institutes are focused on research and development activities related to rHu albumin, which is expected to drive growth of the global rHu albumin market over the forecast period. For instance, in June 2019, The First Hospital of Jilin University, a leading national research university located in Changchun, China, initiated a phase I, single-center, randomized, double-blind, placebo-controlled single dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of recombinant human albumin injection in healthy volunteers for treatment of ascites.

Increasing research and development activities of rHu albumin in the region is expected to drive growth of the global rHu albumin market. For instance, according to a study published in clinicaltrials.gov, a trial, which started on April 8, 2021, is being conducted by Protgen Ltd, a research and development-oriented high-tech enterprise, based in Beijing, China. The trial is aimed at adopting a single-center, randomized, double-blind, dose-escalation, placebo-controlled design to evaluate the safety, tolerability, pharmacokinetics, and efficacy of a single administration of recombinant human serum albumin in healthy subjects. The study is estimated to be completed by December 31, 2022.

Key features of the study

This report provides an in-depth analysis of the global rHu albumin market , provides market size (USD Bn), and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global rHu albumin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Merck KGaA, HiMedia Laboratories Pvt. Ltd., Albumin Bioscience, Albumedix, ScienCell Research Laboratories, Inc., InVitria, Lazuline Biotech Private Limited, Lee Biosolutions, Inc., Abcam Plc, and Shandong Kingtone Biotechnology Co.,Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The Global rHu Albumin Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global rHu albumin market

Market Segmentation

By Source
- Oryza sativa
- Pichia pastoris
- Others
By Application
- Cell Culture Media
- Nutrient and stabilizer
- Medium Supplement
- Stem Cell Therapy
- Drug Formulations
- Cryopreservation
- Others
By End User
- Pharmaceutical and Biotechnological Industry
- Research Institutes
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Merck KGaA
- HiMedia Laboratories Pvt. Ltd.
- Albumin Bioscience
- Albumedix
- ScienCell Research Laboratories, Inc.
- InVitria
- Lazuline Biotech Private Limited
- Lee Biosolutions, Inc.
- Abcam Plc
- Shandong Kingtone Biotechnology Co.,Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Porter's Analysis
Industry Trends
Key Highlights
Epidemiology
Reimbursement Scenario
Regulatory Scenario
Product Launch and Approvals
Acquisition and Collaboration Scenario

4. Global rHu Albumin Market, By Source, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Oryza Sativa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pichia pastoris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global rHu Albumin Market, By Application, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Cell Culture Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Nutrient and stabilizer
  - Medium Supplement
Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Drug Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cryopreservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global rHu Albumin Market, By End User, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Pharmaceutical & Biotechnology Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global rHu Albumin Market, By Region, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
North America
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country/Region, 2021-2033 (USD Bn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- Merck KGaA
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- HiMedia Laboratories Pvt. Ltd.
- Albumin Bioscience
- Albumedix
- ScienCell Research Laboratories, Inc.
- InVitria
- Lazuline Biotech Private Limited
- Lee Biosolutions, Inc.
- Abcam Plc
- Shandong Kingtone Biotechnology Co.,Ltd.